Back to results
US 2011/0257111 A1Published application
Hydroxyethlamino Sulfonamide Derivatives
OwnerScott L. Harbeson, Carig E. Masseinventors
Life of this patent
Estimating the term…
Abstract
This invention relates to novel hydroxyethylamino sulfonamides and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound with the ability to act as an HIV (human immunodeficiency virus) protease inhibitor.
Claims30
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- each Y is independently selected from hydrogen and deuterium;
- at least one of Y4, Y5a, Y5b, Y6a and Y6b is deuterium;
- R1 is hydrogen or —(CR3R4—O)n—R5;
- R2 is an isobutyl group having 0-9 deuterium;
- R3 and R4 are independently selected from H and C1-C4 alkyl;
- R5 is selected from an α-amino acid, —C(O)R6, —P(O)—(OM)2 and —S(O)—OM;
- R6 is hydrogen or an optionally substituted C1-C7 alkyl;
- each M is H, or a cation independently selected from Li+, Na+, K+, Mg2+, Ca2+, Ba2+, and NH4+;
- and
- n is 0 or 1.
8 more elements
A compound of Formula IIa:
- or a salt thereof,
- wherein:
- each Y is independently selected from hydrogen and deuterium.
A compound of Formula IIb:
- or a salt thereof,
- wherein:
- each Y is independently selected from hydrogen and deuterium.
Dependencies are inferred from the claim text.